openPR Logo
Press release

Huateng Pharma Introduces New Cosmetic Actives to Meet Growing Demand for High-Performance Skincare Ingredients

08-27-2025 10:57 AM CET | Health & Medicine

Press release from: Hunan Huateng Pharmaceutical Co., Ltd.

Huateng Pharma, a global leader in specialty chemicals, has expanded its product portfolio to include a new line of high-quality cosmetic ingredients. The launch addresses the increasing demand for effective, safe, and readily available actives for modern skincare and personal care formulations.
The new offerings are now available for immediate delivery and include several key ingredients:
Diethylamino Hydroxybenzoyl Hexyl Benzoate (CAS 302776-68-7): A REACH-registered UVA filter that provides broad-spectrum sun protection. This ingredient is ideal for use in advanced sunscreens and anti-aging products, meeting strict European safety standards.
Tetrahydrocurcumin (CAS 36062-04-1): A powerful antioxidant celebrated for its skin-brightening and anti-inflammatory properties. It helps protect skin from environmental damage and promotes a more even, radiant complexion.
Piroctone Olamine (CAS 68890-66-4): A highly effective antifungal agent commonly used in anti-dandruff shampoos and scalp treatments. It targets the root cause of dandruff while remaining gentle on the skin.
Reliable Supply Backed by Advanced Manufacturing
Huateng Pharma's ability to provide a consistent and scalable supply of these ingredients is powered by its advanced chemical manufacturing capabilities. The company uses a range of specialized processes, including hydrogenation, chlorination, and cryogenic reaction, to ensure flexibility and efficiency in production. This technical expertise allows Huateng Pharma to handle everything from standard catalog orders to complex, custom synthesis projects.
The company's commitment to quality is further supported by a 5,000-square-meter R&D center equipped with nearly 100 high-end analytical instruments, including a 400 MHz NMR system and Agilent LC/MS. These resources enable rapid product development and quality control, ensuring every batch meets the highest standards.
An integrated production system allows Huateng Pharma to seamlessly scale from small-scale lab synthesis to large-scale commercial production, providing partners with reliable supply chains and consistent product quality.
"We are committed to providing our partners with the high-quality raw materials they need to accelerate innovation and development in the skincare and personal care markets," said Brenda Xie of Huateng Pharma.

Website: https://us.huatengsci.com
Email: sales@huatengusa.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: + 86 731-82251112 EXT 818
Headoffice: Building E1, Lugu Corporation Plaza, High-Tech Industrial Development Zone, Changsha City, Hunan Province, P.R.China

Hunan Huateng Pharmaceutical Co., Ltd. is a world-leading supplier of PEG derivatives, pharmaceutical intermediates, and specialty chemicals. With a strong focus on both R&D and GMP-grade commercial production, Huateng Pharma supports the global pharmaceutical, biotechnology, and personal care industries with comprehensive, high-quality chemical solutions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Huateng Pharma Introduces New Cosmetic Actives to Meet Growing Demand for High-Performance Skincare Ingredients here

News-ID: 4160768 • Views:

More Releases from Hunan Huateng Pharmaceutical Co., Ltd.

Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine …
Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical developers worldwide. This compound has gained attention for its multifunctional properties and critical role in drug discovery and development. N-Benzylhydroxylamine Hydrochloride features a unique nitrogen-oxygen (N-O) functional group, which enables its wide-ranging applications in medicinal chemistry, including: Metal Chelation for Iron Overload Disorders: Its
Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CPHI Japan 2025
Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CP …
Changsha, China - 18 March 2025 - Hunan Huateng Pharmaceutical Co., Ltd., a global leader in PEG derivatives and CDMO services for APIs and intermediates, is pleased to announce its participation in CPHI Japan 2025. The company will exhibit its comprehensive product lines and cutting-edge capabilities at Booth No. 4X-06, located at Tokyo Big Sight, Tokyo, Japan, from April 9th to 11th, 2025. Huateng Pharma is dedicated to providing robust support
Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval
Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval
Changsha, China - Hunan Huateng Pharmaceutical Co., Ltd. (Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. Food and Drug Administration (FDA), under DMF No. 040600. This achievement highlights Huateng Pharma's dedication to meeting the highest regulatory standards and further strengthens its commitment to supporting

All 4 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the